Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D01UVA
|
||||
Former ID |
DIB021017
|
||||
Drug Name |
tagitinin A
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [531847] | ||
Structure |
Download2D MOL |
||||
Formula |
C19H28O7
|
||||
InChI |
InChI=1S/C19H28O7/c1-9(2)16(21)25-13-7-18(5)14(20)8-19(23,26-18)10(3)6-12-15(13)11(4)17(22)24-12/h9-10,12-15,20,23H,4,6-8H2,1-3,5H3/t10-,12+,13+,14-,15-,18+,19+/m0/s1
|
||||
InChIKey |
HREHFPZHVCNOMQ-XNNFIIJVSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | mRNA of PPAR-gamma | Target Info | Agonist | [531847] | |
PANTHER Pathway | CCKR signaling map ST | ||||
WikiPathways | Wnt Signaling Pathway Netpath | ||||
Nuclear Receptors in Lipid Metabolism and Toxicity | |||||
Differentiation of white and brown adipocyte | |||||
Regulation of Lipid Metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha) | |||||
Transcriptional Regulation of White Adipocyte Differentiation | |||||
Adipogenesis | |||||
SREBP signalling | |||||
Nuclear Receptors | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.